Abstract
Objectives
The objective of this study was to discover unknown differentially expressed genes (DEGs) associated with bronchopulmonary dysplasia (BPD), analyze their functions and enriched signaling pathways, and identify hub genes correlating with BPD incidence and evolvement.
Results
Of 1289 DEGs identified, 568 were downregulated and 721 were upregulated. The DEGs were mainly associated with oxidative stress, angiogenesis, extracellular matrix, inflammation, cell cycle, and protein binding. Eight DEGs were identified as hub genes, including C-X-C motif chemokine ligand 5 (Cxcl5), connective tissue growth factor (Ctgf), interleukin 6 (IL6), matrix metallopeptidase 9 (Mmp9), mitogen-activated protein kinase 14 (Mapk14), platelet and endothelial cell adhesion molecule 1 (Pecam1), TIMP metallopeptidase inhibitor 1 (Timp1), and TIMP metallopeptidase inhibitor 2 (Timp2). IL6 mRNA and protein expression levels were significantly increased in the peripheral blood of neonates with BPD.
Conclusions
Hence, BPD involves complex biological changes. Our findings indicate that inflammation and angiogenesis may play major roles in BPD pathogenesis and that IL6 has the potential to serve as a biomarker for early BPD diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
References
Abman SH, Bancalari E, Jobe A (2017) The evolution of bronchopulmonary dysplasia after 50 years. Am J Respir Crit Care Med 195:421–424. https://doi.org/10.1164/rccm.201611-2386ed
Albertson DG, Pinkel D (2003) Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 12:R154–R152. https://doi.org/10.1093/hmg/ddg261
Alvira CM, Morty RE (2017) Can we understand the pathobiology of bronchopulmonary dysplasia? J Pediatr 190:27–37. https://doi.org/10.1016/j.jpeds.2017.08.041
Bader GD, Hogue CW (2003) An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform 18:S15. https://doi.org/10.1186/s12859-017-1920-5
Baran J, Gerner M, Haeussler M, Nenadic G, Bergman CM (2011) pubmed2ensembl: a resource for mining the biological literature on genes. PLoS One 6:e24716. https://doi.org/10.1371/journal.pone.0024716
Barrett T, Wilhite SE, Ledoux P et al (2013) NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res 41:D991–D995. https://doi.org/10.1093/nar/gks1193
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8:S11. https://doi.org/10.1186/1752-0509-8-s4-s11
Cline MS, Smoot M, Cerami E et al (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2:2366–2382. https://doi.org/10.1038/nprot.2007.324
Croft D, O'Kelly G, Wu G et al (2011) Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 39:D691–D697. https://doi.org/10.1093/nar/gkq1018
Firsova AB, Cole TJ, Mollard R (2014) Transient vascular and long-term alveolar deficits following a hyperoxic injury to neonatal mouse lung. BMC Pulm Med 14:59. https://doi.org/10.1186/1471-2466-14-59
Fukuhara K, Nakashima T, Abe M, Masuda T, Hamada H, Iwamoto H, Fujitaka K, Kohno N, Hattori N (2017) Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals. Free Radic Biol Med 106:1–9. https://doi.org/10.1016/j.freeradbiomed.2017.02.014
Hosford GE, Fang X, Olson DM (2004) Hyperoxia decreases matrix metalloproteinase-9 and increases tissue inhibitor of matrix metalloproteinase-1 protein in the newborn rat lung: association with arrested alveolarization. Pediatr Res 56:26–34. https://doi.org/10.1203/01.pdr.0000130658.45564.1f
Islam JY, Keller RL, Aschner JL, Hartert TV, Moore PE (2015) Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia. Am J Respir Crit Care Med 192:134–156. https://doi.org/10.1164/rccm.201412-2142pp
Ito K, Murphy D (2013) Application of ggplot2 to pharmacometric graphics. CPT Pharmacomet Syst Pharmacol 2:e79. https://doi.org/10.1038/psp.2013.56
Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH (2000) Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279:L600–L607. https://doi.org/10.1152/ajplung.2000.279.3.l600
Jung EY, Park KH, Han BR, Cho SH, Yoo HN, Lee J (2017) Amniotic fluid infection, cytokine levels, and mortality and adverse pulmonary, intestinal, and neurologic outcomes in infants at 32 weeks' gestation or less. J Korean Med Sci 32:480–487. https://doi.org/10.3346/jkms.2017.32.3.480
Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353–D361. https://doi.org/10.1093/nar/gkw1092
Ke Y, Karki P, Zhang C, Li Y, Nguyen T, Birukov KG, Birukova AA (2019) Mechanosensitive Rap1 activation promotes barrier function of lung vascular endothelium under cyclic stretch. Mol Biol Cell 30:959–974. https://doi.org/10.1091/mbc.e18-07-0422
Kim CB (2007) MAPK-ing out the pathways in lung stem cell regulation. Cell Stem Cell 1:11–13. https://doi.org/10.1016/j.stem.2007.05.007
Lee C, An J, Kim JH, Kim ES, Kim SH, Cho YK, Cha DH, Han MY, Lee KH, Sheen YH (2015) Low levels of tissue inhibitor of metalloproteinase-2 at birth may be associated with subsequent development of bronchopulmonary dysplasia in preterm infants. Korean J Pediatr 58:415–420. https://doi.org/10.3345/kjp.2015.58.11.415
Leroy S, Caumette E, Waddington C, Hébert A, Brant R, Lavoie PM (2018) A time-based analysis of inflammation in infants at risk of bronchopulmonary dysplasia. J Pediatr 192:60–65.e1. https://doi.org/10.1016/j.jpeds.2017.09.011
Liao J, Kapadia VS, Brown LS, Cheong N, Longoria C, Mija D, Ramgopal M, Mirpuri J, McCurnin DC, Savani RC (2015) The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia. Nat Commun 6:8977. https://doi.org/10.1038/ncomms9977
Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B (2019) WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res 47:W199–W205. https://doi.org/10.1093/nar/gkz401
Mohamed WA, Niyazy WH, Mahfouz AA (2011) Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants. J Trop Pediatr 57:385–388. https://doi.org/10.1093/nar/gkz401
Nold MF, Mangan NE, Rudloff I et al (2013) Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. Proc Natl Acad Sci U S A 110:14384–14389. https://doi.org/10.1073/pnas.1306859110
Northway WH Jr, Rosan RC, Porter DY (1967) Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276:357–368. https://doi.org/10.1056/nejm196702162760701
Ozsurekci Y, Aykac K (2016) Oxidative stress related diseases in newborns. Oxid Med Cell Longev 2016:1–9. https://doi.org/10.1155/2016/2768365
Pasha AB, Chen XQ, Zhou GP (2018) Bronchopulmonary dysplasia: pathogenesis and treatment. Exp Ther Med 16:4315–4321. https://doi.org/10.3892/etm.2018.6780
Pisoschi AM, Pop A (2015) The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem 97:55–74. https://doi.org/10.1016/j.ejmech.2015.04.040
Principi N, Di Pietro GM, Esposito S (2018) Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies. J Transl Med 16:36. https://doi.org/10.1186/s12967-018-1417-7
Rudloff I, Cho SX, Bui CB, McLean C, Veldman A, Berger PJ, Nold MF, Nold-Petry CA (2017) Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia. J Cell Mol Med 21:1128–1138. https://doi.org/10.1111/jcmm.13044
Szklarczyk D, Gable AL, Lyon D et al (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47:D607–D613. https://doi.org/10.1093/nar/gky1131
The Gene Ontology Consortium (2017) Expansion of the gene ontology knowledgebase and resources. Nucleic Acids Res 45:D331–D338. https://doi.org/10.1093/nar/gkw1108
Thébaud B, Ladha F, Michelakis ED et al (2005) Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 112:2477–2486. https://doi.org/10.1161/circulationaha.105.541524
Van Quickelberghe E, De Sutter D, van Loo G, Eyckerman S, Gevaert K (2018) A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. Sci Data 5:180289. https://doi.org/10.1038/sdata.2018.289
Villamor-Martinez E, Álvarez-Fuente M, Ghazi AMT, Degraeuwe P, Zimmermann LJI, Kramer BW, Villamor E (2019) Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants: A systematic review, meta-analysis, and metaregression. JAMA Netw Open 2:e1914611. https://doi.org/10.1001/jamanetworkopen.2019.14611
Wang CY, Shang M, Zhou CL, Feng LZ, Zhou QS, Hu K (2019) Mechanism of Cxc chemokine ligand 5 (CXCL5)/Cxc chemokine receptor 2 (CXCR2) bio-axis in mice with acute respiratory distress syndrome. Med Sci Monit 25:5299–5305. https://doi.org/10.12659/msm.915835
Wang X, Cui H, Wu S (2019) CTGF: A potential therapeutic target for bronchopulmonary dysplasia. Eur J Pharmacol 860:172588. https://doi.org/10.1016/j.ejphar.2019.172588
Wu D, Liang M, Dang H, Fang F, Xu F, Liu C (2018) Hydrogen protects against hyperoxia-induced apoptosis in type II alveolar epithelial cells via activation of PI3K/Akt/Foxo3a signaling pathway. Biochem Biophys Res Commun 495:1620–1627. https://doi.org/10.1016/j.bbrc.2017.11.193
Xu X, Yuan B, Shi Z, Liang Q, Huang H, Yin X, Sheng X, Nie N, Fang H (2015) Identification of crucial genes in ventilator associated pneumonia through protein-protein interaction network. Exp Lung Res 41:316–323. https://doi.org/10.3109/01902148.2015.1032447
Yang M, Chen BL, Huang JB, Meng YN, Duan XJ, Chen L, Li LR, Chen Y-P (2017) Angiogenesis-related genes may be a more important factor than matrix metalloproteinases in bronchopulmonary dysplasia development. Oncotarget 8:18670–18679. https://doi.org/10.18632/oncotarget.14722
Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10:1523. https://doi.org/10.1038/s41467-019-09234-6
Funding
This study was funded by the National Natural Science Foundation of China (Grant Number 81800634) and the Key Technologies R&D Program of Tianjin (Grant Number 18ZXRHSY00170).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by WY and MJ. The first draft of the manuscript was written by WY and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yan, W., Jiang, M. & Zheng, J. Identification of key pathways and differentially expressed genes in bronchopulmonary dysplasia using bioinformatics analysis. Biotechnol Lett 42, 2569–2580 (2020). https://doi.org/10.1007/s10529-020-02986-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-020-02986-y